Resistencia antimicrobiana en Helicobacter pylori: Aspectos clínicos y moleculares

5Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the complexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance.

Cite

CITATION STYLE

APA

Vallejos M, C., Cerda A, O., Valenzuela V, M., & Toledo A, H. (2003, November). Resistencia antimicrobiana en Helicobacter pylori: Aspectos clínicos y moleculares. Revista Medica de Chile. https://doi.org/10.4067/s0034-98872003001100014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free